Benazepril/hctz 20/25mg Tablets

Manufacturer GLENMARK PHARMACEUTICALS Active Ingredient Benazepril and Hydrochlorothiazide(ben AY ze pril & hye droe klor oh THYE a zide) Pronunciation ben AY ze pril & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antihypertensive
🧬
Pharmacologic Class
Angiotensin-converting enzyme (ACE) inhibitor / Thiazide diuretic
🤰
Pregnancy Category
Category D
FDA Approved
Mar 1995
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medication is a combination of two drugs: an ACE inhibitor (benazepril) and a diuretic (hydrochlorothiazide). It works by relaxing blood vessels and helping your body get rid of extra salt and water, which lowers your blood pressure. It's used to treat high blood pressure.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, take it exactly as directed by your doctor. Carefully read all the information provided with your prescription, and follow the instructions closely. Establish a routine by taking your medication at the same time every day. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

It's essential to note that this medication may increase your urine production. To minimize sleep disturbances, try to avoid taking your medication too close to bedtime. Unless your doctor advises you to limit your fluid intake, drink plenty of non-caffeinated liquids to stay hydrated.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, away from direct light and moisture. Avoid storing your medication in a bathroom, as the heat and humidity can affect its potency. Keep your medication in a secure location, out of the reach of children and pets, to prevent accidental ingestion or overdose.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily, with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Limit alcohol intake as it can further lower blood pressure.
  • Follow a low-sodium diet as recommended by your doctor.
  • Engage in regular physical activity.
  • Maintain a healthy weight.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.
  • Stay hydrated, especially in hot weather or during exercise, but avoid excessive fluid intake unless advised by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Benazepril/HCTZ 20/25 mg once daily
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

initial_therapy: Not recommended as initial therapy for hypertension. Should be used after titration with individual components or if patient's blood pressure is not adequately controlled on monotherapy.
usual_maintenance: Benazepril 10-20 mg / HCTZ 12.5-25 mg once daily. The 20/25 mg strength is typically for patients requiring higher doses of both components.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
⚕️

Dose Adjustments

Renal Impairment:

Mild: CrCl > 30 mL/min: No specific dose adjustment for the combination is typically needed, but monitor renal function.
Moderate: CrCl 30-80 mL/min: Use with caution. Initial dose of benazepril should be lower (e.g., 5 mg). Hydrochlorothiazide may be less effective below CrCl 30 mL/min.
Severe: CrCl < 30 mL/min: Contraindicated or not recommended due to the hydrochlorothiazide component's ineffectiveness and potential for accumulation of benazeprilat. Consider alternative therapy.
Dialysis: Benazeprilat is dialyzable, but hydrochlorothiazide is not significantly. Not recommended for patients on dialysis due to the HCTZ component.

Hepatic Impairment:

Mild: Use with caution. Benazepril is a prodrug activated in the liver. Thiazides should be used with caution in severe hepatic impairment as they may precipitate hepatic coma.
Moderate: Use with caution. Monitor closely for signs of hepatic encephalopathy.
Severe: Not recommended or contraindicated due to risk of hepatic coma with HCTZ.

Pharmacology

🔬

Mechanism of Action

Benazepril is an ACE inhibitor. It prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, leading to decreased systemic vascular resistance, reduced aldosterone secretion (which decreases sodium and water reabsorption), and increased bradykinin levels (contributing to vasodilation). Hydrochlorothiazide is a thiazide diuretic. It inhibits sodium reabsorption in the distal convoluted tubules, leading to increased excretion of sodium, chloride, and water. It also increases potassium and bicarbonate excretion and decreases calcium excretion.
📊

Pharmacokinetics

Absorption:

Bioavailability: Benazepril: ~37% (as benazeprilat); Hydrochlorothiazide: ~65-75%
Tmax: Benazepril (as benazeprilat): 1-2 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Benazepril: Food does not significantly affect absorption; Hydrochlorothiazide: Food may increase absorption slightly but is not clinically significant.

Distribution:

Vd: Benazepril (as benazeprilat): ~9 L/kg; Hydrochlorothiazide: ~0.8-1.7 L/kg
ProteinBinding: Benazepril (as benazeprilat): ~95%; Hydrochlorothiazide: ~40-68%
CnssPenetration: Limited for both components

Elimination:

HalfLife: Benazepril (as benazeprilat): 10-11 hours (effective half-life); Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Not available
ExcretionRoute: Benazepril (as benazeprilat): Renal (primarily) and biliary; Hydrochlorothiazide: Renal (unchanged)
Unchanged: Benazepril: <1% (as benazepril); Hydrochlorothiazide: ~95% (unchanged)
⏱️

Pharmacodynamics

OnsetOfAction: Benazepril: ~1 hour; Hydrochlorothiazide: ~2 hours
PeakEffect: Benazepril: 2-4 hours; Hydrochlorothiazide: 4-6 hours
DurationOfAction: Benazepril: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

When pregnancy is detected, discontinue Benazepril/Hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:

Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Kidney problems: Inability to pass urine, changes in urine output, blood in the urine, or significant weight gain.
High blood sugar: Confusion, drowsiness, unusual thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Fluid and electrolyte imbalances: Mood changes, confusion, muscle pain or weakness, irregular heartbeat, severe dizziness or fainting, increased thirst, seizures, fatigue, weakness, decreased appetite, changes in urine output, dry mouth, dry eyes, or severe nausea and vomiting.
Persistent cough: A cough that does not go away.
Stomach pain: Severe or persistent stomach pain.
Eye problems: Changes in vision or eye pain, which can occur within hours to weeks of starting this medication. If left untreated, these problems can lead to permanent vision loss.
Liver problems: Dark urine, fatigue, decreased appetite, nausea, stomach pain, light-colored stools, vomiting, or yellow skin and eyes. In rare cases, liver problems can be fatal.

Other Potential Side Effects

While many people may not experience any side effects or only minor ones, it is essential to be aware of the following:

Common side effects: Dizziness, tiredness, weakness, cough, or headache. If these symptoms bother you or persist, contact your doctor or seek medical attention.
Skin cancer: Rarely, people taking hydrochlorothiazide may develop certain types of skin cancer. Protect your skin from the sun and follow your doctor's recommendations for skin checks. If you notice any changes in the color or size of a mole, or any new or changing skin lump or growth, contact your doctor immediately.

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting (especially when standing up)
  • Swelling of the face, lips, tongue, or throat (angioedema) - seek emergency medical attention immediately.
  • Difficulty breathing or swallowing
  • Persistent dry cough
  • Signs of high potassium (muscle weakness, slow or irregular heartbeat)
  • Signs of low potassium (muscle cramps, weakness, irregular heartbeat)
  • Signs of kidney problems (little or no urination, swelling in feet/ankles, unusual tiredness)
  • Yellowing of skin or eyes, dark urine, severe stomach pain (signs of liver problems)
  • Sudden eye pain or vision changes (rare, but can indicate acute angle-closure glaucoma)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction and its symptoms.
A known sulfa allergy.
A history of angioedema, a severe and potentially life-threatening reaction characterized by symptoms such as swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness.
High calcium levels in your blood.
Inability to urinate.
Current or planned use of the following medications:
+ Azilsartan
+ Candesartan
+ Eprosartan
+ Fimasartan
+ Irbesartan
+ Losartan
+ Olmesartan
+ Telmisartan
+ Valsartan
Use of a medication containing aliskiren, especially if you have diabetes or kidney problems.
Use of dofetilide.
Recent use (within the last 36 hours) of a medication containing sacubitril.
Breastfeeding or plans to breastfeed.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to verify the safety of taking this medication. Do not initiate, stop, or adjust the dosage of any medication without consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and be cautious when climbing stairs.

Monitoring Your Condition
If you have diabetes (high blood sugar), closely monitor your blood sugar levels. Check your blood pressure as directed by your healthcare provider. Additionally, have your blood work and other laboratory tests done as scheduled by your doctor.

Interference with Lab Tests
This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

Dietary Considerations
If you are on a low-salt or salt-free diet, consult with your doctor. Also, if you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, discuss this with your doctor.

Over-the-Counter (OTC) Products and Interactions
Before using OTC products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult with your doctor.

Interactions with Other Medications
If you take cholestyramine or colestipol, consult with your pharmacist about how to take these medications with this drug. Before using alcohol, marijuana or other forms of cannabis, or prescription or OTC medications that may cause drowsiness, discuss this with your doctor.

Potential Side Effects
Be aware of the following potential side effects:

Gout attacks: Monitor for symptoms
Lupus: This medication can activate or worsen lupus. Report any new or worsening symptoms to your doctor immediately
High cholesterol and triglyceride levels: If you have a history of high cholesterol or triglycerides, discuss this with your doctor
Low white blood cell counts: This can increase the risk of infection, particularly in people with kidney problems. Seek medical attention if you experience symptoms like fever, chills, or sore throat
Dehydration: In hot weather or during physical activity, drink plenty of fluids to prevent fluid loss. Inform your doctor if you experience excessive sweating, fluid loss, vomiting, or diarrhea, as this can lead to low blood pressure
Angioedema: A severe and potentially life-threatening reaction that may be more common in Black patients
* Age-related precautions: If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Dizziness, lightheadedness, fainting
  • Tachycardia (fast heart rate) or bradycardia (slow heart rate)
  • Electrolyte imbalances (e.g., hyperkalemia, hypokalemia, hyponatremia)
  • Dehydration
  • Acute renal failure

What to Do:

Call 911 or Poison Control (1-800-222-1222) immediately. Treatment is supportive, including IV fluids for hypotension, correction of electrolyte imbalances, and monitoring of vital signs and renal function.

Drug Interactions

🚫

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or moderate to severe renal impairment)
  • Sacubitril/valsartan (within 36 hours of ACE inhibitor dose)
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) and potassium supplements (increased risk of hyperkalemia)
  • Lithium (increased serum lithium levels and toxicity)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) including COX-2 inhibitors (attenuation of antihypertensive effect, increased risk of renal impairment, especially in dehydrated or elderly patients)
  • Other antihypertensives (additive hypotensive effects)
  • Dual blockade of the Renin-Angiotensin System (RAS) with ARBs or aliskiren (increased risk of hypotension, hyperkalemia, and renal impairment)
  • Corticosteroids (may antagonize diuretic effect of HCTZ)
  • Digitalis glycosides (increased risk of digitalis toxicity due to hypokalemia/hypomagnesemia from HCTZ)
  • Insulin and oral antidiabetic agents (HCTZ may decrease glucose tolerance, requiring dose adjustment of antidiabetic agents)
🟡

Moderate Interactions

  • Cholestyramine and colestipol resins (may impair absorption of HCTZ)
  • Muscle relaxants, non-depolarizing (prolonged effect due to HCTZ)
  • Pressor amines (e.g., norepinephrine) (decreased response to pressor amines due to HCTZ)
  • Allopurinol (increased risk of hypersensitivity reactions with HCTZ)
  • Tetracyclines (increased risk of uremia with HCTZ)
  • Barbiturates, narcotics, or alcohol (additive orthostatic hypotension)
🟢

Minor Interactions

  • Not specifically listed as minor, but general caution with other medications that affect blood pressure or electrolytes.

Monitoring

🔬

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy.

Timing: Prior to initiation

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: ACE inhibitors can cause hyperkalemia; thiazides can cause hypokalemia, hyponatremia, hypomagnesemia, and hypercalcemia.

Timing: Prior to initiation

Renal Function (BUN, Serum Creatinine, eGFR)

Rationale: ACE inhibitors can cause acute kidney injury, especially in patients with renal artery stenosis or pre-existing renal impairment. HCTZ is less effective in severe renal impairment.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: Benazepril is metabolized in the liver; HCTZ can rarely cause hepatic dysfunction.

Timing: Prior to initiation

Uric Acid

Rationale: Hydrochlorothiazide can increase serum uric acid levels.

Timing: Prior to initiation

Blood Glucose

Rationale: Hydrochlorothiazide can impair glucose tolerance.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, as clinically indicated (e.g., weekly after initiation/dose change, then monthly/quarterly)

Target: <130/80 mmHg or as per guideline/individualized target

Action Threshold: Persistent elevation above target or symptomatic hypotension

Serum Electrolytes (Potassium, Sodium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 or >150 mEq/L, or symptomatic electrolyte imbalance

Renal Function (BUN, Serum Creatinine, eGFR)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months or as clinically indicated

Target: Stable, within patient's baseline range; eGFR >60 mL/min/1.73m²

Action Threshold: Increase in serum creatinine >30% from baseline, or significant decrease in eGFR

Uric Acid

Frequency: Periodically, especially if patient has history of gout or symptoms develop

Target: Within normal limits

Action Threshold: Symptomatic hyperuricemia or gout flares

Blood Glucose

Frequency: Periodically, especially in diabetic patients or those at risk

Target: Within target range for diabetic/non-diabetic patients

Action Threshold: Significant hyperglycemia

👁️

Symptom Monitoring

  • Dizziness or lightheadedness (especially upon standing)
  • Persistent dry cough (ACE inhibitor effect)
  • Swelling of face, lips, tongue, or throat (angioedema - rare but serious)
  • Unusual fatigue or weakness
  • Muscle cramps or weakness (electrolyte imbalance)
  • Nausea, vomiting, or excessive thirst (dehydration, electrolyte imbalance)
  • Signs of gout (joint pain, swelling)
  • Signs of liver problems (yellowing skin/eyes, dark urine, severe stomach pain)

Special Patient Groups

🤰

Pregnancy

Contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, and death). Discontinue as soon as pregnancy is detected.

Trimester-Specific Risks:

First Trimester: Limited data, but potential risk cannot be excluded. Exposure during the first trimester is not associated with major congenital malformations, but caution is advised.
Second Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, and death).
Third Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, and death).
🤱

Lactation

Both benazeprilat and hydrochlorothiazide are excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., hypotension, hyperkalemia, and effects on renal function from benazeprilat; and potential for hypokalemia, and interference with bilirubin metabolism from HCTZ), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderately Safe - potential for adverse effects, monitor infant for hypotension, electrolyte imbalance, and signs of dehydration).
👶

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

Use with caution. Elderly patients may be more sensitive to the hypotensive and electrolyte-altering effects. Start with lower doses and monitor renal function and electrolytes closely. HCTZ may be less effective in elderly patients with reduced renal function.

Clinical Information

💎

Clinical Pearls

  • This combination is typically used when monotherapy with either an ACE inhibitor or a thiazide diuretic is insufficient to control blood pressure.
  • Patients should be advised to report any signs of angioedema (swelling of face, lips, tongue, or throat) immediately, as this is a life-threatening emergency.
  • Monitor for orthostatic hypotension, especially at the start of therapy, with dose increases, or in volume-depleted patients.
  • Counsel patients on the importance of avoiding potassium supplements or salt substitutes unless specifically advised by their physician due to the ACE inhibitor component.
  • Thiazide diuretics can increase serum uric acid and glucose levels; monitor patients with a history of gout or diabetes closely.
  • Patients should be advised to inform their healthcare provider if they become pregnant or plan to become pregnant due to the severe fetal toxicity risk.
🔄

Alternative Therapies

  • Other classes of antihypertensives (e.g., ARBs, Calcium Channel Blockers, Beta-blockers, other diuretics)
  • Monotherapy with an ACE inhibitor (e.g., Benazepril)
  • Monotherapy with a thiazide diuretic (e.g., Hydrochlorothiazide)
💰

Cost & Coverage

Average Cost: Varies widely, e.g., $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to consult with your pharmacist. If you have any questions or concerns about this medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information about the medication taken, the amount consumed, and the time it occurred.